The Betaseron Desicion

Home Page » Business and Industry

Berlex

Related Essays

Ms

with support from family and friends and the help of medical doctors. WORKS CITED Berlex Laboratories, Inc. Betaseron. 28 October 2005. . Biogen Idec

Doing Business Internationally

such as American Express, Air Products and Chemicals, AT&T, Avon Products, BASF, Berlex, Citigroup, Citrix, Corning, DaimlerChrysler, Ernst & Young, IBM, Lucent

Strategic

2011 annual report 2011 circadian annual report A Milestones We have achieved all of our milestones set in the past 18 months, including: demonstration

What Are Adolescents Perceptions Of Health Literacy

What are Adolescents Perceptions of Health Literacy? A Review of the article Early Adolescents Perceptions of Health and Health Literacy Carrie Virgil Gillette

Submitted by sracampbell to the category Business and Industry on 12/08/2011 01:02 PM

Save Paper

Report This Essay

The Betaseron Decision

Case Study

Executive Summary:

Berlex Labratories has developed a drug, Betaseron, as a treatment of Multiple Sclerosis. The FDA has approved the drug ahead of schedule, leaving the supply far behind the demand. Berlex must find a way to handle the supply, distribution, and price.

Financial Analysis:

Berlex has a medication that works and people need it. There is a market of approximately 100,000 people in America. With an expected price of $10,000, this is a drug worth $1 billion per year.

However, Berlex will not see this revenue for a few years. Since the FDA approved the drug two years ahead of schedule, the supply does not meet the demand. Berlex’s supplier, Chiron Corporation, estimates to have enough of the drug to supply to 12,000-20,000 patients in 1993. This will yield $120,000,000 to 200,000,000 in revenues.

They will increase production in following years. They should be able to provide 40,000 patients by 1994, providing $400,000,000 in revenues. They do not expect to meet demand until 1996.

SWOT Analysis:

Strengths:

Berlex has...